| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +920K | 73.9% | $10.98 | +$10.1M |
| Sells | 6 | -325K | 26.1% | $12.87 | -$4.19M |
| Net | -3 | +595K | 47.8% | +$5.92M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Orbimed Advisors Llc | Director, 10%+ Owner | $228M | +$5M | +2.24% | Jan 23, 2024 |
| Peter A. Thompson | Director, 10%+ Owner | $228M | +$5M | +2.24% | Jun 10, 2024 |
| Holdings A/S Novo | 10%+ Owner | $95.8M | Sep 14, 2022 | ||
| Kevin Koch | President and CEO, Director | $2.13M | -$59.6K | -2.72% | Aug 12, 2024 |
| R. Michael Carruthers | Chief Financial Officer | $1.1M | -$1.46M | -57% | Aug 12, 2024 |
| Donovan Joanne M. | Cmo | $814K | -$69.6K | -7.88% | Aug 12, 2024 |
| Behrad Derakhshan | Chief Business Officer | $691K | -$233K | -25.2% | Aug 12, 2024 |
| Russell Alan J | Chief Scientific Officer, Director | $574K | -$1.64M | -74.1% | Aug 12, 2024 |
| John R. Moore | General Counsel | $499K | -$723K | -59.2% | Aug 12, 2024 |
| Semigran Marc | Chief Development Officer | $437K | Aug 12, 2024 | ||
| Fox Jonathan C | Director | $171K | +$101K | +144% | Jun 10, 2024 |
| Jonathan Root | Director | Jun 10, 2024 | |||
| Badreddin Edris | Director | Jun 10, 2024 | |||
| Laura Brege | Director | Jun 10, 2024 | |||
| Arlene Morris | Director | Jun 10, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|